Articles & Issues

Alert me when new Articles in Press are available. Add Articles in Press Alert   Request Articles in Press Alert via email or RSS Feed   Request RSS feed of Articles in Press

80 Articles

Article Title Author(s) Type (Status) Available Online
Blinded and uniform cause of death verification in a lung cancer CT screening trial

DOI: 10.1016/j.lungcan.2012.04.018

N. Horeweg, R.J. van Klaveren, H.J.M. Groen, J.-W.J. Lammers, C. Weenink, K. Nackaerts, W. Mali, M. Oudkerk, H.J. de Koning et al. Full-length article
(In Press Corrected Proof)
24 May 2012
Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation

DOI: 10.1016/j.lungcan.2012.04.012

June Koo Lee, Tae Min Kim, Youngil Koh, Se-Hoon Lee, Dong-Wan Kim, Yoon-Kyung Jeon, Doo Hyun Chung, Seok-Chul Yang, Young Tae Kim, Young-Whan Kim, Dae Seog Heo, Yung-Jue Bang et al. Short communication
(In Press Corrected Proof)
23 May 2012
New vision, new hope: Building momentum in NSCLC

DOI: 10.1016/j.lungcan.2012.05.090

Other contents
(In Press Corrected Proof)
21 May 2012
Non-steroidal anti-inflammatory drugs and small cell lung cancer risk in the VITAL study

DOI: 10.1016/j.lungcan.2012.04.015

Theodore M. Brasky, Christina S. Baik, Christopher G. Slatore, John D. Potter, Emily White et al. Full-length article
(In Press Corrected Proof)
21 May 2012
Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy

DOI: 10.1016/j.lungcan.2012.04.016

Seok-Hyun Kim, Gyeong-Won Lee, Min Jeong Lee, Yu Ji Cho, Yi Yeong Jeong, Ho-Cheol Kim, Jong Duk Lee, Young Sil Hwang, In-Suk Kim, Suee Lee, Sung Yong Oh et al. Full-length article
(In Press Corrected Proof)
21 May 2012
Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: A systematic review of contemporary randomized trials

DOI: 10.1016/j.lungcan.2012.04.017

B.E. Kiely, M. Alam, P. Blinman, M.H.N. Tattersall, M.R. Stockler et al. Full-length article
(In Press Corrected Proof)
21 May 2012
Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC)

DOI: 10.1016/j.lungcan.2012.04.011

Nasrollah Erfani, Shayesteh Mofakhami Mehrabadi, Mohammad Ali Ghayumi, Mohammad Reza Haghshenas, Zahra Mojtahedi, Abbas Ghaderi, Davar Amani et al. Full-length article
(In Press Corrected Proof)
21 May 2012
Successful erlotinib rechallenge for leptomeningeal metastases of lung adenocarcinoma after erlotinib-induced interstitial lung disease: A case report and review of the literature

DOI: 10.1016/j.lungcan.2012.04.013

Yosuke Togashi, Katsuhiro Masago, Yasuhiro Hamatani, Yuichi Sakamori, Hiroki Nagai, Young Hak Kim, Michiaki Mishima et al. Short communication
(In Press Corrected Proof)
14 May 2012
Chemotherapy for pulmonary large cell neuroendocrine carcinoma: Similar to that for small cell lung cancer or non-small cell lung cancer?

DOI: 10.1016/j.lungcan.2012.04.009

Jong-Mu Sun, Myung-Ju Ahn, Jin Seok Ahn, Sang-Won Um, Hojoong Kim, Hong Kwan Kim, Young Soo Choi, Joungho Han, Jhingook Kim, O Jung Kwon, Young Mog Shim, Keunchil Park et al. Full-length article
(In Press Corrected Proof)
14 May 2012
National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China

DOI: 10.1016/j.lungcan.2012.04.014

Cong Xue, Zhihuang Hu, Wei Jiang, Yuanyuan Zhao, Fei Xu, Yan Huang, Hongyun Zhao, Jingxun Wu, Yang Zhang, Liping Zhao, Jing Zhang, Likun Chen, Li Zhang et al. Full-length article
(In Press Corrected Proof)
14 May 2012
Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung

DOI: 10.1016/j.lungcan.2012.03.025

Shinichiro Ryuge, Yuichi Sato, Shi Xu Jiang, Guoqin Wang, Toshihide Matsumoto, Ken Katono, Hayato Inoue, Akira Iyoda, Yukitoshi Satoh, Hirokuni Yoshimura, Noriyuki Masuda et al. Full-length article
(In Press Corrected Proof)
09 May 2012
Characterization of vitamin D receptor (VDR) in lung adenocarcinoma

DOI: 10.1016/j.lungcan.2012.04.010

So Hee Kim, Guoan Chen, Amanda N. King, Chae Kyung Jeon, Paul J. Christensen, Lili Zhao, Robert U. Simpson, Dafydd G. Thomas, Thomas J. Giordano, Dean E. Brenner, Bruce Hollis, David G. Beer, Nithya Ramnath et al. Full-length article
(In Press Corrected Proof)
07 May 2012
Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer

DOI: 10.1016/j.lungcan.2012.03.009

David R. Spigel, F. Anthony Greco, Mark S. Rubin, Dianna Shipley, Dana S. Thompson, Eric T. Lubiner, Janice F. Eakle, Raven Quinn, Howard A. Burris, John D. Hainsworth et al. Full-length article
(In Press Corrected Proof)
07 May 2012
Clinical and molecular analysis of synchronous double lung cancers

DOI: 10.1016/j.lungcan.2012.04.003

Junichi Arai, Tomoshi Tsuchiya, Masahiro Oikawa, Koji Mochinaga, Tomayoshi Hayashi, Koh-ichiro Yoshiura, Kazuhiro Tsukamoto, Naoya Yamasaki, Keitaro Matsumoto, Takuro Miyazaki, Takeshi Nagayasu et al. Full-length article
(In Press Corrected Proof)
07 May 2012
ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy

DOI: 10.1016/j.lungcan.2012.04.005

Millie Das, Jonathan W. Riess, Paul Frankel, Erich Schwartz, Robyn Bennis, H. Ben Hsieh, Xiohe Liu, Janey C. Ly, Lisa Zhou, Jorge J. Nieva, Heather A. Wakelee, Richard H. Bruce et al. Full-length article
(In Press Corrected Proof)
03 May 2012
The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer

DOI: 10.1016/j.lungcan.2012.04.008

Ioannis Gioulbasanis, Athanasios Pallis, Panagiotis J. Vlachostergios, Alexandros Xyrafas, Zoe Giannousi, Isidora-Eleni Perdikouri, Michalitsa Makridou, Dionysia Kakalou, Vassilios Georgoulias et al. Full-length article
(In Press Corrected Proof)
01 May 2012
Single agent maintenance therapy for advanced stage non-small cell lung cancer: A meta-analysis

DOI: 10.1016/j.lungcan.2012.03.019

Madhusmita Behera, Taofeek K. Owonikoko, Zhengjia Chen, Scott A. Kono, Fadlo R. Khuri, Chandra P. Belani, Suresh S. Ramalingam et al. Full-length article
(In Press Corrected Proof)
30 April 2012
Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinoma

DOI: 10.1016/j.lungcan.2012.04.004

Adnan Hasanovic, Daphne Ang, Andre L. Moreira, Maureen F. Zakowski Full-length article
(In Press Corrected Proof)
30 April 2012
Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer

DOI: 10.1016/j.lungcan.2012.04.001

Pirooz Poursoltan, Nicola Currey, Laurent Pangon, Christa van Kralingen, Christina I. Selinger, Annabelle Mahar, Wendy A. Cooper, Catherine W. Kennedy, Brian C. McCaughan, Ronald Trent, Maija R.J. Kohonen-Corish et al. Full-length article
(In Press Corrected Proof)
30 April 2012
Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases

DOI: 10.1016/j.lungcan.2012.03.028

Susan Guo, Chandana A. Reddy, Samuel T. Chao, John H. Suh, Gene H. Barnett, Michael A. Vogelbaum, Gregory M. Videtic et al. Full-length article
(In Press Corrected Proof)
30 April 2012
Expression and prognostic significance of centromere protein A in human lung adenocarcinoma

DOI: 10.1016/j.lungcan.2012.04.007

Qing Wu, Yi-Ming Qian, Xiang-Li Zhao, Shou-Mei Wang, Xiao-Jun Feng, Xin-Fang Chen, Shu-Hui Zhang et al. Full-length article
(In Press Corrected Proof)
30 April 2012
Angiolymphatic invasion exerts a strong impact on surgical outcomes for stage I lung adenocarcinoma, but not non-adenocarcinoma

DOI: 10.1016/j.lungcan.2012.04.002

Tatsuya Kato, Keidai Ishikawa, Masato Aragaki, Masaaki Sato, Kenzo Okamoto, Tetsuya Ishibashi, Mitsuhito Kaji et al. Full-length article
(In Press Corrected Proof)
30 April 2012
Peroxiredoxins and tropomyosins as plasma biomarkers for lung cancer and asbestos exposure

DOI: 10.1016/j.lungcan.2012.03.024

Annina Rostila, Anne Puustinen, Tuula Toljamo, Katri Vuopala, Irmeli Lindström, Tuula A. Nyman, Panu Oksa, Tapio Vehmas, Sisko L. Anttila et al. Full-length article
(In Press Corrected Proof)
26 April 2012
Prospective study of transarterial infusion of docetaxel and cisplatin to treat non-small-cell lung cancer in patients contraindicated for standard chemotherapy

DOI: 10.1016/j.lungcan.2012.04.006

Masanori Nakanishi, Yoshimasa Yoshida, Toshiki Natazuka Full-length article
(In Press Corrected Proof)
26 April 2012
Use of erlotinib throughout pregnancy: A case-report of a patient with metastatic lung adenocarcinoma

DOI: 10.1016/j.lungcan.2012.03.026

Giovanna Rivas, Nestor Llinás, Carlos Bonilla, Juan Rubiano, Javier Cuello, Natalia Arango et al. Short communication
(In Press Corrected Proof)
25 April 2012
Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer

DOI: 10.1016/j.lungcan.2012.03.027

Eunkyung Ko, Yujin Kim, Seong-Eun Park, Eun Yoon Cho, Jungho Han, Young Mog Shim, Joobae Park, Duk-Hwan Kim et al. Full-length article
(In Press Corrected Proof)
25 April 2012
Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer

DOI: 10.1016/j.lungcan.2012.03.011

Myung-Ju Ahn, James Chih-Hsin Yang, Jun Liang, Jin-Hyoung Kang, Qingyu Xiu, Yuh-Min Chen, Julie Michelle Blair, Guangbin Peng, Carlos Linn, Mauro Orlando et al. Full-length article
(In Press Corrected Proof)
25 April 2012
Proteomics-based identification of secreted protein dihydrodiol dehydrogenase 2 as a potential biomarker for predicting cisplatin efficacy in advanced NSCLC patients

DOI: 10.1016/j.lungcan.2012.03.016

Peng Kuang, Caicun Zhou, Xuefei Li, Shengxiang Ren, Bing Li, Yongsheng Wang, Jiayu Li, Liang Tang, Jie Zhang, Yinmin Zhao et al. Full-length article
(In Press Corrected Proof)
25 April 2012
EGFR mutations as a predictive marker of cytotoxic chemotherapy

DOI: 10.1016/j.lungcan.2012.03.020

Jin Hyun Park, Se-Hoon Lee, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Seok-Chul Yang, Young Whan Kim, Dae Seog Heo et al. Full-length article
(In Press Corrected Proof)
23 April 2012
EBUS-TBNA in patients presented with superior vena cava syndrome

DOI: 10.1016/j.lungcan.2012.03.015

Matthew K. Wong, Terence C. Tam, David C. Lam, Mary S. Ip, James C. Ho et al. Full-length article
(In Press Corrected Proof)
23 April 2012
Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients

DOI: 10.1016/j.lungcan.2012.03.023

Xiaojing Xu, Huayi Ren, Boting Zhou, Yingchun Zhao, Ruixia Yuan, Rui Ma, Honghao Zhou, Zhaoqian Liu et al. Full-length article
(In Press Corrected Proof)
19 April 2012
Risk factors for radiation-induced lung toxicity in patients with non-small cell lung cancer who received postoperative radiation therapy

DOI: 10.1016/j.lungcan.2012.03.017

Lujun Zhao, Wei Ji, Guangfei Ou, Jima Lv, Jun Liang, Qinfu Feng, Zongmei Zhou, Luhua Wang, Weibo Yin et al. Full-length article
(In Press Corrected Proof)
18 April 2012
Perineal and colonic metastases in two cases of malignant mesothelioma

DOI: 10.1016/j.lungcan.2012.03.021

Bhajneek Grewal, Gordon Reid, Hannah Lord Short communication
(In Press Corrected Proof)
16 April 2012
Prognostic factors in patients with advanced non-small cell lung cancer: Data from the phase III FLEX study

DOI: 10.1016/j.lungcan.2012.03.010

R. Pirker, J.R. Pereira, A. Szczesna, J. von Pawel, M. Krzakowski, R. Ramlau, I. Vynnychenko, K. Park, W.E.E. Eberhardt, F. de Marinis, S. Heeger, T. Goddemeier, K.J. O’Byrne, U. Gatzemeier et al. Full-length article
(In Press Corrected Proof)
13 April 2012
Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer

DOI: 10.1016/j.lungcan.2012.03.007

Heather Male, Vijay Patel, Mark A. Jacob, Emma Borrego-Diaz, Kun Wang, Derek A. Young, Amanda L. Wise, Chao Huang, Peter Van Veldhuizen, Amy O’Brien-Ladner, Stephen K. Williamson, Sarah A. Taylor, Ossama Tawfik, Tuba Esfandyari, Faris Farassati et al. Full-length article
(In Press Corrected Proof)
12 April 2012
Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma

DOI: 10.1016/j.lungcan.2012.03.008

Saly Al-Taei, Josephine Salimu, Jason F. Lester, Seamus Linnane, Madusha Goonewardena, Richard Harrop, Malcolm D. Mason, Zsuzsanna Tabi et al. Full-length article
(In Press Corrected Proof)
12 April 2012
Efficacy and safety of maintenance erlotinib in Asian patients with advanced non-small-cell lung cancer: A subanalysis of the phase III, randomized SATURN study

DOI: 10.1016/j.lungcan.2012.03.012

Yi-Long Wu, Joo-Hang Kim, Keunchil Park, Adel Zaatar, Gaëlle Klingelschmitt, Christina Ng et al. Full-length article
(In Press Corrected Proof)
11 April 2012
Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy

DOI: 10.1016/j.lungcan.2012.03.018

Nobuhiro Kanaji, Shuji Bandoh, Tomoya Ishii, Akira Tadokoro, Naoki Watanabe, Takayuki Takahama, Reiji Haba, Osamu Imataki, Hiroaki Dobashi, Takuya Matsunaga et al. Full-length article
(In Press Corrected Proof)
11 April 2012
Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group

DOI: 10.1016/j.lungcan.2012.03.002

Shigeki Umemura, Kazuya Tsubouchi, Hiroshige Yoshioka, Katsuyuki Hotta, Nagio Takigawa, Keiichi Fujiwara, Naokatsu Horita, Yoshihiko Segawa, Noboru Hamada, Ichiro Takata, Hiromichi Yamane, Haruhito Kamei, Katsuyuki Kiura, Mitsune Tanimoto et al. Full-length article
(In Press Corrected Proof)
10 April 2012
Thymoma and solid-organ transplantation

DOI: 10.1016/j.lungcan.2012.03.014

Nicolas Guibert, Laurent Brouchet, Isabelle Rouquette, Alain Didier, Lionel Rostaing, Nassim Kamar, Julien Mazieres et al. Short communication
(In Press Corrected Proof)
09 April 2012
The gefitinib long-term responder (LTR)—A cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)

DOI: 10.1016/j.lungcan.2012.03.003

Sandra Gottschling, Esther Herpel, Wilfried E.E. Eberhardt, David F. Heigener, Jürgen R. Fischer, Claus-Henning Köhne, Cornelius Kortsik, Thomas Kuhnt, Thomas Muley, Michael Meister, Helge G. Bischoff, Peter Klein, Ines Moldenhauer, Philipp A. Schnabel, Michael Thomas, Roland Penzel et al. Full-length article
(In Press Corrected Proof)
09 April 2012
Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene

DOI: 10.1016/j.lungcan.2012.03.013

Takayuki Fukui, Yasushi Yatabe, Yoshihisa Kobayashi, Kenji Tomizawa, Simon Ito, Shunzo Hatooka, Keitaro Matsuo, Tetsuya Mitsudomi et al. Full-length article
(In Press Corrected Proof)
09 April 2012
VEGF and sVEGFR-1 in malignant pleural effusions: Association with survival and pleurodesis outcomes

DOI: 10.1016/j.lungcan.2012.03.006

C.E. Hooper, K.T. Elvers, G.I. Welsh, A.B. Millar, N.A. Maskell et al. Full-length article
(In Press Corrected Proof)
09 April 2012
SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors

DOI: 10.1016/j.lungcan.2012.02.017

Sarah M. Rausch, Brian D. Gonzalez, Matthew M. Clark, Christi Patten, Sara Felten, Heshan Liu, Yafei Li, Jeff Sloan, Ping Yang et al. Full-length article
(In Press Corrected Proof)
05 April 2012
Aspirin and non-aspirin non-steroidal anti-inflammatory drug use and risk of lung cancer

DOI: 10.1016/j.lungcan.2012.03.005

Wei-Yen Lim, Khoon Leong Chuah, Philip Eng, Swan Swan Leong, Elaine Lim, Tow Keang Lim, Alan Ng, Wee Teng Poh, Augustine Tee, Ming Teh, Agus Salim, Adeline Seow et al. Full-length article
(In Press Corrected Proof)
05 April 2012
Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients

DOI: 10.1016/j.lungcan.2012.03.004

Heae Surng Park, June Koo Lee, Dong-Wan Kim, Kimary Kulig, Tae Min Kim, Se-Hoon Lee, Yoon-Kyung Jeon, Doo Hyun Chung, Dae Seog Heo et al. Full-length article
(In Press Corrected Proof)
02 April 2012
Generalisability of the results of the Dutch–Belgian randomised controlled lung cancer CT screening trial (NELSON): Does self-selection play a role?

DOI: 10.1016/j.lungcan.2012.02.021

C.M. van der Aalst, C.A. van Iersel, R.J. van Klaveren, F.J.M. Frenken, J. Fracheboud, S.J. Otto, P.A. de Jong, M. Oudkerk, H.J. de Koning et al. Full-length article
(In Press Corrected Proof)
29 March 2012
Exploratory analysis of activation of PTEN–PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)

DOI: 10.1016/j.lungcan.2012.02.022

S. Cedrés, M.A. Montero, P. Martinez, A. Martinez, V. Rodríguez-Freixinós, D. Torrejon, A. Gabaldon, M. Salcedo, S. Ramon y Cajal, E. Felip et al. Full-length article
(In Press Corrected Proof)
29 March 2012
Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC)

DOI: 10.1016/j.lungcan.2012.03.001

Yi-Zhen Liu, Yan-Yi Jiang, Jia-Jie Hao, Shan-Shan Lu, Tong-Tong Zhang, Li Shang, Jian Cao, Xin Song, Bo-Shi Wang, Yan Cai, Qi-Min Zhan, Ming-Rong Wang et al. Full-length article
(In Press Corrected Proof)
28 March 2012
Re-irradiation plus regional hyperthermia for recurrent non-small cell lung cancer: A potential modality for inducing long-term survival in selected patients

DOI: 10.1016/j.lungcan.2012.02.018

Takayuki Ohguri, Hajime Imada, Katsuya Yahara, Seung Dae Moon, Shinsaku Yamaguchi, Kazuhiro Yatera, Hiroshi Mukae, Takeshi Hanagiri, Fumihiro Tanaka, Yukunori Korogi et al. Full-length article
(In Press Corrected Proof)
26 March 2012
Emphysema detected on computed tomography and risk of lung cancer: A systematic review and meta-analysis

DOI: 10.1016/j.lungcan.2012.02.019

Benjamin M. Smith, Lancelot Pinto, Nicole Ezer, Nicola Sverzellati, Shigeo Muro, Kevin Schwartzman et al. Full-length article
(In Press Corrected Proof)
22 March 2012
Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data

DOI: 10.1016/j.lungcan.2012.02.016

María S. Degese, Javier E. Mendizabal, Norberto A. Gandini, J. Silvio Gutkind, Alfredo Molinolo, Stephen M. Hewitt, Alejandro C. Curino, Omar A. Coso, María M. Facchinetti et al. Full-length article
(In Press Corrected Proof)
15 March 2012
Retrospective study of erlotinib in patients with advanced squamous lung cancer

DOI: 10.1016/j.lungcan.2012.02.012

Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Kuo-Hsuan Hsu, Hsuan-Yu Chen, Gee-Chen Chang et al. Full-length article
(In Press Corrected Proof)
15 March 2012
Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung

DOI: 10.1016/j.lungcan.2012.02.013

Jin Gu Lee, Sewha Kim, Hyo Sup Shim Full-length article
(In Press Corrected Proof)
15 March 2012
Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: A phase II multicenter study of the Hellenic Oncology Research Group

DOI: 10.1016/j.lungcan.2012.02.002

Giannis Mountzios, Christos Emmanouilidis, Nikolaos Vardakis, Emmanouil Kontopodis, Dora Hatzidaki, Evagelos Popis, Niki Karachaliou, Athanassios Kotsakis, Maria Agelidou, Vassilis Georgoulias et al. Full-length article
(In Press Corrected Proof)
15 March 2012
shRNA-mediated knockdown of Bmi-1 inhibit lung adenocarcinoma cell migration and metastasis

DOI: 10.1016/j.lungcan.2012.02.015

Xiuxiang Meng, Yifang Wang, Xiangyu Zheng, Chunqing Liu, Benli Su, Huiling Nie, Baoxia Zhao, Xinyu Zhao, Hong Yang et al. Full-length article
(In Press Corrected Proof)
15 March 2012
Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer

DOI: 10.1016/j.lungcan.2012.02.011

Luhua Wang, Shixiu Wu, Guangfei Ou, Nan Bi, Wenfeng Li, Hua Ren, Jianzhong Cao, Jun Liang, Junling Li, Zongmei Zhou, Jima Lv, Xiangru Zhang et al. Full-length article
(In Press Corrected Proof)
14 March 2012
A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study)

DOI: 10.1016/j.lungcan.2012.02.004

H. LeCaer, L. Greillier, R. Corre, H. Jullian, J. Crequit, L. Falchero, C. Dujon, H. Berard, A. Vergnenegre, C. Chouaid, the GFPC 0505 Team et al. Full-length article
(In Press Corrected Proof)
14 March 2012
Oncologists’ assessments of lung cancer patient and family disagreements regarding treatment decision making

DOI: 10.1016/j.lungcan.2012.02.008

Laura A. Siminoff, Lindsey Dorflinger, Amma Agyemang, Sherman Baker, Maureen Wilson-Genderson et al. Full-length article
(In Press Corrected Proof)
09 March 2012
Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy

DOI: 10.1016/j.lungcan.2012.02.006

Kazuhiko Shien, Shinichi Toyooka, Kouichi Ichimura, Junichi Soh, Masashi Furukawa, Yuho Maki, Takayuki Muraoka, Norimitsu Tanaka, Tsuyoshi Ueno, Hiroaki Asano, Kazunori Tsukuda, Masaomi Yamane, Takahiro Oto, Katsuyuki Kiura, Shinichiro Miyoshi et al. Full-length article
(In Press Corrected Proof)
05 March 2012


Note to users: The section "Articles in Press" contains peer reviewed and accepted articles to be published in this journal. When the final article is assigned to an issue of the journal, the "Article in Press" version will be removed from this section and will appear in the associated journal issue. Please be aware that "Articles in Press" do not have all bibliographic details available yet. There are three types of "Articles in Press":
  • Accepted Manuscripts: these are manuscripts that have been selected for publication. They have not been typeset and the text may change before final publication.
  • Uncorrected proofs: these are articles that are not yet finalized and that will be corrected by the authors. Therefore the text could change before final publication. Uncorrected proofs may be temporarily unavailable for production reasons.
  • Corrected proofs: these are articles containing the authors' corrections. The content of the article will usually remain unchanged, and possible further corrections are fairly minor. Typically the only difference with the finally published article is that specific issue and page numbers have not yet been assigned.